Embecta Corp
Open
SectorHealthcare
4.96 0.61
Overview
Share price change
24h
Min
4.8
Max
4.99
Income | 25M 21M |
|---|---|
Sales | 50M 272M |
P/E Sector Avg | 3.395 57.366 |
EPS | 0.56 |
Dividend yield | 8.8 |
Profit margin | 7.766 |
Employees | 1,850 |
EBITDA | 17M 62M |
Dividend yield Sector Avg | 8.80% 2.16% |
|---|---|
Next Earnings | 24 Nov 2026 |
Next Dividend date | 15 Sept 2026 |
Next Ex Dividend date | 27 Aug 2026 |
Market Cap | 62M 283M |
|---|---|
Previous open | 4.35 |
Previous close | 4.96 |
News Sentiment
By Acuity
74%
26%
313 / 340 Healthcare
Embecta Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Embecta Corp Forecast
Sentiment
By Acuity
313 / 340 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Embecta Corp
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.